Developmental Delay (Disorder)
16
6
6
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
1 terminated out of 16 trials
90.0%
+3.4% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 9 completed trials
Clinical Trials (16)
Mindful Movement And GAME BASED Training In Developmental Delay
Behavioral Parent Training to Address Early Childhood Disruptive Behavior Using the DOCS Parenting Programs
Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation
Genotype/Phenotype Correlation of MORC2 Mutations
Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Global Developmental Delay
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
Reference Values of Intraepidermal Nerve Fiber Density in Children and Small Fiber Neuropathy in Neurodevelopmental Disorders
The Belgian Genome Resource to Resolve Rare Diseases
Animal-Assisted Therapy in Pediatric Autism Spectrum Disorders
Promoting Playfulness
Use of Long Read Genome Sequencing in Patients Suffering From Neurodevelopmental Troubles
Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Providing Speech Therapy Awareness in Private Schools
Creative Music Therapy for Premature Infants
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay